Weimai Qingtong Medical Technology (Wuxi) Co., Ltd. announced that it has received nears CNY 100 million in a round of funding on March 13, 2024. The transaction involved participation from new investor CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.88 CNY | +1.27% |
|
+7.11% | -31.23% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.23% | 2.68B | |
-11.24% | 237B | |
+15.86% | 19.88B | |
0.00% | 19.32B | |
+6.35% | 11.87B | |
-18.44% | 8.83B | |
+3.31% | 6.69B | |
-2.28% | 5.69B | |
-7.28% | 4.06B | |
-11.76% | 4B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.